Search by Drug Name or NDC

    NDC 69238-1155-09 Ezetimibe and Simvastatin 10; 10 mg/1; mg/1 Details

    Ezetimibe and Simvastatin 10; 10 mg/1; mg/1

    Ezetimibe and Simvastatin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is EZETIMIBE; SIMVASTATIN.

    Product Information

    NDC 69238-1155
    Product ID 69238-1155_d2799fe1-dd94-4839-b771-d264a95b75f2
    Associated GPIs 39994002300320
    GCN Sequence Number 057859
    GCN Sequence Number Description ezetimibe/simvastatin TABLET 10 MG-10MG ORAL
    HIC3 M4M
    HIC3 Description ANTIHYPERLIP.HMG COA REDUCT INHIB-CHOLEST.AB.INHIB
    GCN 23121
    HICL Sequence Number 026505
    HICL Sequence Number Description EZETIMIBE/SIMVASTATIN
    Brand/Generic Generic
    Proprietary Name Ezetimibe and Simvastatin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ezetimibe and Simvastatin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 10; 10
    Active Ingredient Units mg/1; mg/1
    Substance Name EZETIMIBE; SIMVASTATIN
    Labeler Name Amneal Pharmaceuticals NY LLC
    Pharmaceutical Class Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208831
    Listing Certified Through 2024-12-31

    Package

    NDC 69238-1155-09 (69238115509)

    NDC Package Code 69238-1155-9
    Billing NDC 69238115509
    Package 90 TABLET in 1 BOTTLE (69238-1155-9)
    Marketing Start Date 2017-11-21
    NDC Exclude Flag N
    Pricing Information N/A